Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment

Israel Medical Association Journal

Volumn 3, Issue 9, 2001, Pages 698-699

  Shoenfeld, Y ^a   Levy, Y ^a   Fishman, P ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Chronic lymphocytic leukemia; Immunoglobulin G; Intravenous immunoglobulin; Melanoma; Metastases; Sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERFERON;

ABDOMINAL CANCER; ADULT; ARTICLE; BONE METASTASIS; CANCER SURGERY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; NEVUS; PELVIS CANCER; SARCOMA; SEPSIS; SIDE EFFECT; THORAX CANCER; TREATMENT FAILURE;

ADULT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MELANOMA; NEVUS; TREATMENT FAILURE;

EID: 0035677624     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. High dose intravenous immunoglobulins: A new step in the treatment of systemic lupus erythematosus
2. Prophylactic immune globulin in chronic lymphocytic leukemia
3. Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis
4. Gamma-globulin inhibits tumour spread in mice